fianlimab,cemiplimab
sanofi,regeneron
['fianlimab', 'cemiplimab', 'melanoma']
combination lag3/pd1 - fianlimab and cemiplimab - in advanced melanoma presented by orr 61% activity in poor prognostic groups: high ldh, liver mets activity in low and high pd-l1 and lag expression #asco23 
Melanoma and high risk skin cancer medical oncologist. Studying hereditary and somatic genomics. CA explant in OH. (IO!) Sports fan, geek, and mommy. Tweets=me.